As detailed in Table 14 and visualized in Figure 1, patients with advanced age, cardiovascular disease, or high IL-6 levels had significantly reduced median survival times (12–15 days) and higher mortality rates (40–50%). Here, IL6 is linked to cardiovascular disorder.